Crista Galli Ventures

Crista Galli Ventures is a London-based evergreen venture capital fund founded in 2019, operating as the healthtech investment arm of IPQ Capital — the family office of Dr Fiona Pathiraja and Søren Fryland Møller, who serve as the fund's two partners. Also active from Copenhagen, the firm focuses on European healthtech startups led by clinicians and domain experts, investing at the nexus of biology, technology, and medicine. The evergreen structure allows the fund to maintain long-term positions and support founders through extended development timelines typical of healthcare innovation. Crista Galli invests at Seed and Series A stages, writing checks from €100,000 to £3 million, across digital health, AI-enabled clinical tools, medical devices, and personalized medicine. With 48 investments across the UK, Germany, France, Spain, and the Netherlands, the portfolio includes Bugbiome, Kanjo Health, CardiaTec, Inne, Keleya, Leda Health, and aeon — spanning fertility, cardiology, digital therapeutics, and wearable health monitoring. The firm's clinical and scientific credibility is central to its value proposition. Dr Pathiraja's background as a physician-investor enables Crista Galli to evaluate clinical validity and adoption potential in ways that purely financial investors cannot. The fund backs companies with strong user adoption potential and genuine capacity to solve real-world healthcare problems at scale.